Comera Life Sciences Holdings, Inc. (CMRA)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -18.37 Million USD | -354.31% |
| 2021 | -5.29 Million USD | -148.94% |
| 2020 | -2.12 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q1 | -77.77 Million USD | -2566.96% |
| 2023 Q3 | -2.15 Million USD | -52.57% |
| 2023 Q2 | -1.41 Million USD | 98.18% |
| 2022 Q3 | -3.61 Million USD | 74.51% |
| 2022 Q2 | -14.19 Million USD | -329.43% |
| 2022 Q1 | -3.3 Million USD | -63.34% |
| 2022 FY | -24.03 Million USD | -354.31% |
| 2022 Q4 | -2.91 Million USD | 19.41% |
| 2021 Q4 | -2.02 Million USD | -121.53% |
| 2021 Q3 | -913.7 Thousand USD | 53.87% |
| 2021 Q2 | -1.98 Million USD | -271.31% |
| 2021 Q1 | -533.4 Thousand USD | 0.0% |
| 2021 FY | -5.29 Million USD | -148.94% |
| 2020 FY | -2.12 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| America Great Health | -761.42 Thousand USD | -2313.642% |
| Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -112.905% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 40.232% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 85.193% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -14.305% |
| Better Therapeutics, Inc. | -39.76 Million USD | 53.778% |
| Calithera Biosciences, Inc. | -18.86 Million USD | 2.587% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 48.681% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 49.042% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 83.953% |
| Evolutionary Genomics, Inc. | -2.24 Million USD | -717.43% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 75.415% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 68.894% |
| Innovation1 Biotech Inc. | -5.98 Million USD | -206.899% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 13.694% |
| Molecular Templates, Inc. | -8.12 Million USD | -126.218% |
| Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -21.09% |
| NexImmune, Inc. | -32.34 Million USD | 43.18% |
| Orgenesis Inc. | -55.36 Million USD | 66.803% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 27.253% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -23456.345% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -0.482% |
| Scopus BioPharma Inc. | -11.6 Million USD | -58.297% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 96.792% |
| Statera Biopharma, Inc. | -174.4 Million USD | 89.463% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -412.206% |
| Trevena, Inc. | -40.28 Million USD | 54.385% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -32179.401% |
| Vaccinex, Inc. | -20.25 Million USD | 9.249% |
| Vicapsys Life Sciences, Inc. | -1.18 Million USD | -1454.671% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 64.006% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -136.306% |